Dexcom CEO on the company’s stock performance and how Covid-19 has changed his business

Kevin Sayer, CEO of glucose monitoring systems developer for diabetes management Dexcom, joins CNBC’s “The Exchange” to talk about the company’s stock performance and how has coronavirus changed the business. For access to live and exclusive video from CNBC subscribe to CNBC PRO:

» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:

For info on the best credit cards go to CNBC Select:


Category: News
About The Author